Lys274

Site Information
RLRLRLTkLQQERAR SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 461400

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 )
Disease tissue studied:	liver cancer ( 1 , 2 ) , hepatocellular carcinoma ( 1 , 2 )
Relevant cell line - cell type - tissue:	HepG2 (hepatic) ( 1 , 2 )

References
1	Mitchell J (2005) CST Curation Set: 867; Year: 2005; Biosample/Treatment: cell line, HepG2/TSA; Disease: hepatocellular carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info
2	Mitchell J (2005) CST Curation Set: 868; Year: 2005; Biosample/Treatment: cell line, HepG2/TSA; Disease: hepatocellular carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info